Cognition Therapeutics Inc.

Cognition Therapeutics Inc.

Discovering small molecule therapeutics for Alzheimer's and other neurodegenerative diseases

Cognition Therapeutics welcomes inquiries from potential investors

Please contact Hank Safferstein at 412.770.1621

For more information on Alzheimer’s patient care, go to the Alzheimer Research Forum website

In the News

Jan 20, 2011 - Cognition Therapeutics Completes $2.5M In Series A1 Financing

Sept 17, 2009 - Cognition Therapeutics featured in The Economist’s G20 conference coverage

August 5, 2009 – BioWorld Today profiles Cognition Therapeutics

July 15, 2009 - Cognition Therapeutics Closes Series A Financing to Advance Drug Candidates for Alzeimer's Disease

May 28, 2009 – PghTech Women’s Network raises Alzheimer’s awareness by highlighting cutting-edge research

May 1, 2009 – Cognition Therapeutics Profiled in Pittsburgh Post-Gazette

May 1, 2008 – Cognition’s Chief Science Officer chairs scientific session at SRI 11th Annual Alzheimer’s disease meeting in Boston, MA – summary of CogRx presentation

January 17, 2008 – Cognition Therapeutics celebrates Innovation Work’s 100th Investment

Nov 27, 2007 – Cognition Therapeutics receives funding from Pittsburgh Life Sciences Greenhouse